C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005
C-C chemokine receptor 2 gene polymorphism V64I and C-C chemokine receptor 5 gene polymorphism Δ32 in pulmonary sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006
Chemokine receptor expression by human lung mast cells Source: Annual Congress 2003 - Cell signalling and cytokines in asthma Year: 2003
Functional polymorphism of p53 and CCR5 genes in lung carcinoma and bronchail asthma Source: Eur Respir J 2005; 26: Suppl. 49, 591s Year: 2005
CC chemokine receptor 5 gene polymorphisms in beryllium disease Source: Eur Respir J 2010; 36: 331 Year: 2010
Chemokines and chemokine receptors mRNA expression in whole blood of COPD patients Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010
CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006
The effect of adhesion molecule CEACAM1 and chemokine receptor CXCR4 expression on prognosis of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
T cell chemokine receptor expression in COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Chemokines and chemokine receptors mRNA expression in lavage of COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Expression of the chemokine receptors CXCR1 and CXCR2 on bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004
Polymorphism in C-C Chemokine Receptor 5 (CCR5) increases susceptibility to Löfgren’s syndrome and alters receptor expression as well as functional response. Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021
Polarization of the chemokine receptor CXCR6 according to activation status of human lung T cells Source: Eur Respir J 2003; 22: Suppl. 45, 571s Year: 2003
Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
CCR2, CCR5, their ligands and chemokine receptor-interacting protein FROUNT have impressive effects on pulmonary adenocarcinoma Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease Source: Eur Respir J 2004; 23: 219-223 Year: 2004
Expression of toll-like receptor 3 in alveolar macrophages from patients with COPD Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008
Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA) Source: Eur Respir J 2001; 18: Suppl. 33, 450s Year: 2001
Frequency of TNFα and TNF receptor-1 polymorphisms in SSc patients with and without lung involvement Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001